Estimating the prevalence of illicit opioid use in New York City using multiple data sources

BackgroundDespite concerns about its health and social consequences, little is known about the prevalence of illicit opioid use in New York City. Individuals who misuse heroin and prescription opioids are known to bear a disproportionate burden of morbidity and mortality. Service providers and public health authorities are challenged to provide appropriate interventions in the absence of basic knowledge about the size and characteristics of this population. While illicit drug users are underrepresented in population-based surveys, they may be identified in multiple administrative data sources.MethodsWe analyzed large datasets tracking hospital inpatient and emergency room admissions as well as drug treatment and detoxification services utilization. These were applied in combination with findings from a large general population survey and administrative records tracking prescriptions, drug overdose deaths, and correctional health services, to estimate the prevalence of heroin and non-medical prescription opioid use among New York City residents in 2006. These data were further applied to a descriptive analysis of opioid users entering drug treatment and hospital-based medical care.ResultsThese data sources identified 126,681 cases of opioid use among New York City residents in 2006. After applying adjustment scenarios to account for potential overlap between data sources, we estimated over 92,000 individual opioid users. By contrast, just 21,600 opioid users initiated drug treatment in 2006. Opioid users represented 4 % of all individuals hospitalized, and over 44,000 hospitalizations during the calendar year.ConclusionsOur findings suggest that innovative approaches are needed to provide adequate services to this sizeable population of opioid users. Given the observed high rates of hospital services utilization, greater integration of drug services into medical settings could be one component of an effective approach to expanding both the scope and reach of health interventions for this population.

[1]  M. Olfson,et al.  Improving the Detection of Drug Abuse, Alcohol Abuse, and Depression in Community Health Centers , 2003, Journal of health care for the poor and underserved.

[2]  W. Kissin,et al.  Experiences of a National Sample of Qualified Addiction Specialists Who Have and Have Not Prescribed Buprenorphine for Opioid Dependence , 2006, Journal of addictive diseases.

[3]  B. Grant,et al.  The effect of inmate populations on estimates of DSM-IV alcohol and drug use disorders in the United States. , 2010, The American journal of psychiatry.

[4]  D Wright,et al.  The use of external data sources and ratio estimation to improve estimates of hardcore drug use from the NHSDA. , 1997, NIDA research monograph.

[5]  S. Galea,et al.  Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. , 2003, Addiction.

[6]  W. Lange,et al.  Medical complications of substance abuse. , 1992, Postgraduate medicine.

[7]  Janet B W Williams.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[8]  Politikai rendszerek,et al.  Office of National Drug Control Policy , 2010 .

[9]  T. Palfai,et al.  Screening and Brief Intervention for Unhealthy Drug Use in Primary Care Settings: Randomized Clinical Trials Are Needed , 2010, Journal of addiction medicine.

[10]  B. Frank.  An overview of heroin trends in New York City: past, present and future. , 2000, The Mount Sinai journal of medicine, New York.

[11]  S. Friedman,et al.  Estimating the Prevalence of Injection Drug Use among Black and White Adults in Large U.S. Metropolitan Areas over Time (1992–2002): Estimation Methods and Prevalence Trends , 2008, Journal of Urban Health.

[12]  J. Caylà,et al.  Analytical considerations in the use of capture-recapture to estimate prevalence: case studies of the estimation of opiate use in the metropolitan area of Barcelona, Spain. , 1998, American journal of epidemiology.

[13]  E. Perez-stable,et al.  Depression in medical outpatients. Underrecognition and misdiagnosis. , 1990, Archives of internal medicine.

[14]  M. Stein,et al.  Prevalence and detection of illicit drug disorders among hospitalized patients. , 1996, The American journal of drug and alcohol abuse.

[15]  O. Ekeberg,et al.  Clinical vs. Laboratory Identification of Drugs of Abuse in Patients Admitted for Acute Poisoning , 2006, Clinical toxicology.

[16]  Donald R. Miller,et al.  Using Administrative Data to Identify Mental Illness: What Approach Is Best? , 2010, American journal of medical quality : the official journal of the American College of Medical Quality.

[17]  H. W. Clark,et al.  Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. , 2009, Drug and alcohol dependence.

[18]  D. English,et al.  The quantification of mortality resulting from the regular use of illicit opiates. , 1999, Addiction.

[19]  T. Heeren,et al.  Brief motivational intervention at a clinic visit reduces cocaine and heroin use. , 2005, Drug and alcohol dependence.

[20]  L. Degenhardt,et al.  How many dependent heroin users are there in Australia? , 2000, The Medical journal of Australia.

[21]  M. Farrell,et al.  Estimating the prevalence of problem drug use in inner London: a discussion of three capture-recapture studies. , 1999, Addiction.

[22]  T. Palfai,et al.  The severity of unhealthy alcohol use in hospitalized medical patients , 2006, Journal of General Internal Medicine.

[23]  T. Rhodes,et al.  Estimating prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia. , 2006, Drug and alcohol review.

[24]  Matt Anderson,et al.  European Monitoring Centre for Drugs and Drug Addiction , 2014 .

[25]  Thomas R Kosten,et al.  Challenges in increasing access to buprenorphine treatment for opiate addiction. , 2004, The American journal on addictions.

[26]  M. Frischer,et al.  Methodological guidelines to estimate the prevalence of problem drug use on the local level. , 1999 .

[27]  M A Jansen,et al.  Linking research and service delivery: the unique mission of the Substance Abuse and Mental Health Services Administration. , 1994, NIDA research monograph.

[28]  D. Fiellin.  The First Three Years of Buprenorphine in the United States: Experience to Date and Future Directions , 2007, Journal of addiction medicine.

[29]  R. Room,et al.  Problematic drug use and drug use disorders in EU countries and Norway: An overview of the epidemiology , 2005, European Neuropsychopharmacology.

[30]  S. Friedman,et al.  Estimating the Prevalence of Injection Drug Use among Black and White Adults in Large U.S. Metropolitan Areas over Time (1992–2002): Estimation Methods and Prevalence Trends , 2008, Journal of urban health : bulletin of the New York Academy of Medicine.

[31]  Duncan Stewart,et al.  A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. , 2002, Addiction.

[32]  John F. Hurdle,et al.  Measuring diagnoses: ICD code accuracy. , 2005, Health services research.

[33]  Brady T West,et al.  Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. , 2008, Addictive behaviors.